Cargando…
Redox Control in Acute Lymphoblastic Leukemia: From Physiology to Pathology and Therapeutic Opportunities
Acute lymphoblastic leukemia (ALL) is a hematological malignancy originating from B- or T-lymphoid progenitor cells. Recent studies have shown that redox dysregulation caused by overproduction of reactive oxygen species (ROS) has an important role in the development and progression of leukemia. The...
Autores principales: | Chen, Yongfeng, Li, Jing, Zhao, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155968/ https://www.ncbi.nlm.nih.gov/pubmed/34067520 http://dx.doi.org/10.3390/cells10051218 |
Ejemplares similares
-
The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities
por: Meyer, Lauren K., et al.
Publicado: (2019) -
Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities
por: Kourti, Maria, et al.
Publicado: (2023) -
Editorial: Biomarkers and therapeutic strategies in acute lymphoblastic leukemia
por: Lee, Ki-Young, et al.
Publicado: (2023) -
Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?
por: Allegra, Alessandro, et al.
Publicado: (2022) -
Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)